Trevia®R2 (Ertugliflozin + Sitagliptin) is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both Ertugliflozin and Sitagliptin is appropriate.

Trevia R2 Tablets for oral use contains Ertugliflozin L-pyroglutamic acid, a SGLT2 inhibitor and Sitagliptin phosphate, a DPP-4 inhibitor. Ertugliflozin belongs to the class of potent and selective inhibitors of the

Jan 7, 2025 · By inhibiting the DPP-4 enzyme, Trevia increases the levels of two known active incretin hormones, glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). The incretins are part of an endogenous system involved in the physiologic regulation of glucose homeostasis.

Order Trevia R2 (5/100mg) 14 Tablets Online from Healthwire Pharmacy: Learn about its uses, side effects, Dosage and price in Pakistan. Order now for a hassle-free experience!

Discover Trevia R2 15mg+100mg Tablets, a powerful combination of Ertugliflozin and Sitagliptin. Enhance your diabetes management with this medication.

Monotherapy: This medicine is used for treating type 2 diabetes (condition characterized by elevated glucose levels) that is inadequately controlled by metformin, diet and exercise.

TREVIA contains the active substance sitagliptin which is a member of a class of medicines called DPP-4 inhibitors (dipeptidyl peptidase-4 inhibitors) that lowers blood sugar levels in adult patients with type 2 diabetes mellitus. Type 2 diabetes is also called non-insulin-dependent diabetes mellitus, or NIDDM.

Consult your doctor and discuss your queries related to any medicine or disease. View Trevia R2 15 mg / 100 mg tablets (strip of 7) uses, ... doctor's advice and buy medicines online at 15% discount on online pharmacy Dawaai....Trevia R2 15 mg / …

TREVIA R2 5+100MG Tablet is a combination medication that contains two active ingredients: Ertugliflozin and Sitagliptin. Ertugliflozin belongs to the class of sodium-glucose co-transporter 2 (SGLT2) inhibitors, and Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor.

TREVIA R2 5+100MG Tablet is a combination medication that contains two active ingredients: Ertugliflozin and Sitagliptin. Ertugliflozin belongs to the class of sodium-glucose co-transporter 2 (SGLT2) inhibitors, and Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor.